BetterLife Pharma (BETR.CN) on Wednesday said it appointed Doug Drysdale as executive chair.
Drysdale is currently BetterLife's corporate advisor and a former chief executive officer of Cybin (CYBN), said the company.
"We are delighted to welcome Doug to our Board of Directors," said chief executive Ahmad Doroudian. "His proven global leadership, underscored by a track record of executing multiple successful transactions across diverse markets and therapeutic indications, brings a depth of strategic insight and operational expertise that will meaningfully strengthen BetterLife. Doug's experience navigating complex deal environments and scaling opportunities across jurisdictions will be invaluable as we continue to advance our growth strategy and create long-term shareholder value."
The company's shares were last seen unchanged at $0.065 on the Canadian Securities Exchange.